Study: Omicron evades some but not all monoclonal antibodies
Por um escritor misterioso
Descrição
Several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the omicron variant now sweeping across the United States, researchers reported Jan. 19 in the journal Nature Medicine.
Omicron Appears to Evade Vaccines Better Than Other Variants
COVID, Free Full-Text
Immune Escape Mechanisms of SARS-CoV-2 Delta and Omicron Variants against Two Monoclonal Antibodies That Received Emergency Use Authorization
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies - eBioMedicine
Omicron may sideline two leading drugs against COVID-19
Monoclonal antibodies can't keep Omicron variant in check, 2021-12-27
Viruses, Free Full-Text
Delta-Omicron recombinant escapes therapeutic antibody neutralization - ScienceDirect
Why omicron is more infectious than other coronavirus variants
Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles
de
por adulto (o preço varia de acordo com o tamanho do grupo)
